Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2017-07-11

Clinical Trial Update: Copeptin After Arginine Infusion in Polyuria-Polydipsia Syndrome

View source ↗

Summary

The clinical trial evaluated copeptin response after an arginine infusion in people with polyuria-polydipsia syndrome and in healthy controls. The study status …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • L-Arginine (L-Arginine)

Snippet

Sponsor: University Hospital, Basel, Switzerland | Conditions: Healthy, Polyuria-polydipsia Syndrome | Status: COMPLETED